is bpc 157 harmful Frontiers BPC 157 in Australia: Benefits,
Description
doi: 10.1080/16078454.2021.2010877
Cagrilintide had one of the lowest GI odds ratios among incretin-class compounds in a 2025 network meta-analysis, but combination GI burden has not been formally quantified
Side effects are generally mild and may include slight soreness at the injection site or temporary warmth
The Coroners Court confirmed it was investigating a death related to the use of growth-stimulating peptides (CJC 1295 and ipamorelin) prescribed by a medical practitioner
